• Ruizeng Yang#, Liqiao Hu#, Jing Wang#, Jia Wang, Liang Yuan, Mengying Wu, Lingli He, Wentao Yu, Peihao Chen, Xiaoli Lu, Fangzheng Hu, Haijiao Zhang, Haoran Gao, Xiaodong Wang, Haoen Zhang, Yang Sun, Jinjin Xu, Jing Huang, Hu Zhou, Jidong Zhu, Fang Wei, Yunyun Jin, Yijun Gao, Qiang Fu, Xiangbing Qi*, Jing Yu*, Pilong Li*, Xiaojing He*, Lei Zhang*. Phase separation-based HTS identifies cobimetinib as a YAP-TEAD inhibitor that suppresses hyperactivated YAP-induced cancer progression. Science Translational Medicine 2026 Apr 22;18(846): eadu0814. (cover story)